Supplementary Table S1 from ERK1/2 Phosphorylation Predicts Survival in Recurrent Glioblastoma Following Intracerebral and Adjuvant PD-1/CTLA-4 Immunotherapy: A REMARK-guided Analysis
收藏NIAID Data Ecosystem2026-05-01 收录
数据链接：
官方服务：
资源简介：
Supplementary Table 1. Clinical characteristics and p-ERK quantification of our GBM cohort treated with anti-PD-1 therapy
创建时间：
2024-01-17
